The Administrative Core of the UT Southwestern O'Brien Kidney Center provides scientific and fiscal oversight of the Center. The Administrative Core supports the attainment of the Center's goals through a simple yet effective administrative structure that can readily adapt to the changing needs of investigators and the emergence of new technologies. The Administrative Core insures that the O'Brien Kidney Center efficiently interacts with core users as well as other core facilities, centers, and educational programs at UT Southwestern. Additionally, the Administrative Core oversees the Pilot and Feasibility Program and the Educational Enrichment Programs to insure that they are meeting the needs of the participants.
The specific aims for the next funding cycle are: 1) Provide scientific oversight of the biomedical research cores, 2) Administer the Pilot and Feasibility Program, 3) Support the Educational Enrichment Program, 4) Provide fiscal oversight of the Center's operations, 5) Continue to expand the user base of the Center, and 6) Provide the infrastructure needed to operate the cores and facilitate the interactions with users. To achieve these goals, the UTSW O'Brien Kidney Center is led by an Executive Committee comprised of the Center Director, Associate Director, and the Directors of the P&F Program and Enrichment Program. The Executive Committee meets regularly with the Core Directors to oversee the services and appoint Center Investigators. An External Advisory Committee composed of seven experts in the fields of kidney development, renal physiology and pathophysiology, and CKD meets annually to review the Center and assist with the selection of the P&F projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK079328-07
Application #
8518304
Study Section
Special Emphasis Panel (ZDK1-GRB-6)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
7
Fiscal Year
2013
Total Cost
$307,951
Indirect Cost
$114,271
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Baum, Michel (2016) Luminal angiotensin II stimulates rat medullary thick ascending limb chloride transport in the presence of basolateral norepinephrine. Am J Physiol Renal Physiol 310:F294-9
Tanriover, Bekir; MacConmara, Malcolm P; Parekh, Justin et al. (2016) SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVAL. KI Rep 1:221-229
Zhang, Jiandong; Rudemiller, Nathan P; Patel, Mehul B et al. (2016) Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI. J Am Soc Nephrol 27:2257-64
Srivastava, Anand; Adams-Huet, Beverley; Vega, Gloria L et al. (2016) Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy. J Investig Med 64:1102-8
Baum, Michel (2016) Neonatal nephrology. Curr Opin Pediatr 28:170-2
Yang, Zhufeng; Zimmerman, Susan E; Tsunezumi, Jun et al. (2016) Role of CD34 family members in lumen formation in the developing kidney. Dev Biol 418:66-74
Westover, Arthur N; Nakonezny, Paul A; Barlow, Carolyn E et al. (2016) Heart Rate Recovery and Systolic Blood Pressure Recovery After Maximal Exercise in Prevalent Users of Stimulant Medications. J Clin Psychopharmacol 36:295-7
Jain, Nishank; Li, Xilong; Adams-Huet, Beverley et al. (2016) Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease. Am J Cardiol 117:656-63
Ravikumar, Priya; Menon, Jyothi U; Punnakitikashem, Primana et al. (2016) Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury. Nanomedicine 12:811-21
Vongpatanasin, Wanpen; Peri-Okonny, Poghni; Velasco, Alejandro et al. (2016) Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects. Am J Cardiol 118:849-53

Showing the most recent 10 out of 198 publications